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Utility of Scintigraphic Methods in Patients 
With Fever of Unknown Origin
Elisabeth M. H. A. de Kleijn, MD; Wim J. G. Oyen, MD; Roland A. M. J. Claessens, MD, PhD; 
Frans H. M. Corstens, MD; Jos W. M. van der Meer, MD
Background: We assessed the v
indium Ill-labeled polyclonal human IgG scintigra­
phy in patients with fever of unknown origin that ful­
filled the criteria of temperature of 38.3°C or more, for 
at least 3 weeks and no diagnosis during 1 week of hos­
pital admission. We compared the utility of this tech­
nique with results of scintigraphic techniques reported 
in the literature.
Methods: Data for all patients seen at our university hos­
pital in whom luIn-IgG scanning was performed were 
analyzed and checked for the criteria for fever of un­
known origin. The literature on the utility of scinti­
graphic techniques in patients with fever of unknown 
origin was reviewed.
Results: We studied 24 patients with fever of un­
known origin. In 13 patients, focal m In-lgG accumula­
tion was observed. In nine (38%) of those, the positive 
mIn-IgG scintigram led to the final diagnosis; in the other 
four patients (17%), the scintigraphic findings were not
helpful. In the 11 patients with negative 11 'In-IgG scans, 
extensive diagnostic woi no
the final diagnosis in nine patients (38%), one had an ab­
scess in a renal cyst that was detected several months later, 
and in the other the cause of fever was an infected intra­
venous line. The overall sensitivity and specificity of 
111 In-IgG scintigraphy were 81% and 69%, respectively. 
The positive predictive value was 69% and the negative 
predictive value was 82%,
Conclusions: Our results show that 11'In-IgG scintig­
raphy significantly contributed to the diagnostic pro­
cess in patients with fever of unknown origin. A posi­
tive scan increased the likelihood of finding the cause of 
the fever, and a negative scan ruled out an inflammatory 
component with a high degree of certainty. These data 
compare favorably with data in the literature concern­
ing other radiopharmaceuticals; a larger prospective evalu-
ation e is
(Arch Intern Med. 1995;155:1989-1994)
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EVER OF origin enhances the likelihood of establishing 
a final diagnosis.8
A relatively new and potentially use­
ful for this indication is in-
(FUO) has been defined by 
Petersdorf and Beeson1 as a 
febrile illness of more than 
3 weeks’ duration, docu- 
temperature higher than 38.3°G 
on at least three occasions, and uncertain IgG scintigraphy in the evaluation of vari-
nosis after 1 week of diagnostic ous types of focal inflammation and in- 
workup in the hospital. Currently, a va- fection has been studied. Reports have been
es, in- published in the literature on bone and
di um 111 —labeled polyclonal human IgG
' 'H i  r n _
c reso- . 14,11 , In1
nance imaging, asonogra monary,17 and vascular18 lesions. This tech-
in pa- nique is also applic i
tients with FUO. nic patients, 
convenient i
i
: m g i
e e In-IgG is a
armaceu ti-
gallium 67, blood (WBCs) cal, comparing favorably with other scin-
From the Departments of  
Medicine (Dm de Kleijn and
van der Meer) and Nuclear  
Medicine (Drs Oyen, 
Claessens, and Corstens),
labeled with indium In 111,10"12 and,
m ost rece etium Tc m
labeled BW250/183, an antigranulocyte 
m onoclonal antibody of murine ori­
gin,13 has been applied in patients with 
FUO to detect infectious o
inflammatory foci. A positive scintigram
M W < 4 m
See Patients and Methods
on next page
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PATIENTS AND METHODS
PATIENTS
Records of all patients who underwent m In-IgG scintig­
raphy in our hospital were reviewed for FUO.1 Twenty- 
four patients (11 women and 13 men; mean age, 51 years; 
median, 52 years) fulfilled the criteria for FUO. From our 
studies of FUO carried out during the same period, we found 
that 45% of the patients w ith FUO had undergone 
mln-IgG scintigraphy.
All patients underwent full biochemical and appropri­
ate further investigations, including extensive negative mi­
crobiologic methods, which failed to establish a diagnosis
severe adverse reactions after intravenous or intramuscu­
lar administration of human IgG. Pregnant or lactating 
women were also excluded from this study.
Scintigraphic images were obtained with a gamma cam­
era (Siemens Orbiter, Siemens Inc, Hoffman Estates, 111) 
connected to an image processor (Scintiview, Siemens Inc). 
All images were collected in digital format in a 256X256 
matrix. A medium-energy parallel-hole collimator (173- 
keV peak, 15% symmetric window; 247-keV peak, 15% sym­
metric window) was used.
The mIn-lgG images were acquired 4,24, and 48 hours 
after injection for a preset time of 5, 7.5, and 10 minutes, 
respectively. At least once, 24 hours after injection, spot 
views of the total body were obtained. Single-photon- 
emission computed tomographic images were recorded
within 1 week of admission. These investigations varied from when necessary for more definite localization in three di-
patient to patient; no protocol was followed. The median fol­
low-up of these patients was 216 days (range, 2 to 1500 days).
The final diagnosis was made by the patients’ physi­
cians and checked by one of us (E.M.H.A.K.).
RADIOPHARMACEUTICAL
Human nonspecific polyclonal IgG (Sandoglobulin, San- 
doz AG, Nürnberg, Germany) was conjugated to diethyl­
ene triamine pentaacetic bicyclic anhydride according to the
mensions of areas with increased uptake.
All images were interpreted by three observers, 
“blinded” to the results of the verification procedures. 
Disagreements were resolved by consensus opinion. 
Hyperemic noninflamecl lesions may initially show some 
uptake but no further accumulation of 11’In-IgG with 
time.21 These scans were interpreted as equivocal and 
not pathologic. An m In-IgG scan was interpreted as 
positive only if consistent, focally increasing accumula­
tion could be noted over time. An ia In-IgG scintigram
method described by Hnatowich et al20 and labeled with was considered “true positive” only when this imaging 
indium 111 (indium [m In] chloride, Medgenix Diagnos- procedure was considered helpful in diagnosis.
tics, Fleurus, Belgium). Labeling efficiency was always 
greater than 95%. A dose of 1 to 2 mg of IgG labeled with 
75 MBq of m In was injected intravenously.
IMAGING PROCEDURES
Exclusion criteria for H1In-IgG scintigraphy were agam­
maglobulinemia, selective IgA deficiency, and a history of
The results o f the scintigraphic findings were veri­
fied by clinical, radiographic, and ultrasonographic meth­
ods and preferably by microbiologic methods.
STATISTICS
Differences between groups were analyzed by the Mann- 
Whitney U  test or Student’s t test, when necessary.22
tigraphic techniques, we studied its diagnostic utility in 
patients with FUO.
RESULTS
In .13 (54%) of 24 patients, focal accumulation of activity 
increasing with time was observed. In nine patients (38%), 
scintigraphy was cliagnostically helpful (Table I ); in eight 
of these, inflammatory or infectious foci were identified 
as the cause of the fever (Figure 1 and Figure 2). In four 
other patients (17%), a positive 11 'In-IgG scintigram did 
not lead to the final diagnosis (Table 1).
Table 1 also shows the data for the remaining 11 pa­
tients, in whom a negative or equivocal11'In-IgG scinti­
gram was obtained. In six of those patients, extensive 
workup disclosed no diagnosis; follow-up from the start 
of fever varied from 224 to 929 days (median, 515 days). 
In two patients a malignant neoplasm mos t probably was 
the cause of fever, and one patient had positive blood cul­
tures with Salmonella enteritidis serotype paratyphi A. The 
two remaining patients had infections as the cause of the 
fever despite negative IgG scintigrams; one had an in­
fected renal cyst, diagnosed 3 months after the 
negative mIn-IgG scan, and the other had an infected cen­
tral venous catheter.
If we considered results o f1 uIn-IgG scintigraphy as 
true positive only when this imaging procedure led to 
the diagnosis, sensitivity was 82%, specificity was 69%, 
and positive and negative predictive value was 69% and 
82%, respectively.
Comparison of the erythrocyte sedimentation rate 
of patients with positive scans (mean±SD, 80.8±43,0 
mm/h) with that of patients with negative scans 
(mean±SD, 70.5±47.5 mm/h) yielded no significant dif­
ference (P=,66). Likewise, WBC counts of patients with 
positive scans (mean±SD, 9 .9± 5 .7X 10‘’/L) and pa­
tients with negative scans (mean±SD, 8.0±3.3X107L) 
did not differ significantly (P=.38).
Comparison of the groups with positive and nega- 
ulln-IgG scans showed that a positive scan signifi­
cantly increased the likelihood of reaching a diagnosis: 
in 11 (85%) of 13 patients with a positive scan, a final 
diagnosis was made, compared with only five (45%) of 
11 patients with a negative scan (P=.05).
tive
COMMENT
From this study, it can be concluded that luIn-IgG 
scintigraphy is a promising technique in the workup 
of patients with FUO, as indicated by an overall sensi-
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Table Characteristics of Patients According to Results of Indium In 1 1 1  IgG Scans
Patient/ Fever
Age, y/ E S R , Leukocytes, Duration, Additional
Sex mm/h Clinical Data x  1 09/L wk Localization of Uptake Final Diagnosis Investigationst
True-Positive Scans
1/8 1/F 93 Arthritis of knee, heart 1 1 . 4 4 Right knee Tuberculous arthritis, Puncture, C
m urm ur spondylodiskltis
2/67/F 132 Lu m ba r pain 8.5 8 Left hip, back Spondylodiskitis, arthritis with 
G ro u p  B Streptococcus and 
Propionibacterium acnes
B, C, X
3/23/F 40 Lym phadenopathy, 
abdominal pain, 
arthritis
1 2 .7 7 Right lower abdom en C r o h n ’ s disease Colonoscopy
4/65/M 140 No abdominal 
complaints
26.5 22 Right lower abdom en Ileum metastasis of surgically 
cured lung cancer
X ,  C T, S ,  P E
5/63/M 90 No abdominal 
complaints, steroids
5 .7 3 Right lower abdom en Abscess with Escherichia coli 
after appendicitis
U S , S
6/33/M 70
1
Recurrent abdominal 
pain, no diarrhea
7 .6 7 Ascending colon Ulcerative colitis X ,  colonoscopy, P E
7/48/M 7 2 Polyarthritis, pleural 5.4 8 Both lungs, left hip, knee Nonclassifiable noninfectious Open lung B, C T ,
► effusion Inflam m atory lung disease, 
culture-negative periostitis
U S , C , B , blood, 
D S A
8/46/M 136 L o w  thoracic pain, 
pleural effusion
6.6 11 Right lung Pleural e m p ye m a  and 
spondylitis with 
Staphylococcus aureus
CT, X ,  B , U S ,  C
9/63/F 20 Polyarthritis, diarrhea 
without blood
10 .9 20 No activity in kidney H yd ro n e p h ro sis in colon 
cancer, E  coli in urine
U S , X ,  
colonoscopy,
S, P E
False-Positive Scans
1 0/49/M 50 Fatigue, recurrent fever 
for 5 y
8.1 53 Both hips Aseptic necrosis of hips, no 
cause of fever found
X ,  Tc bone scan, 
U S
1 1/61/M 12 0 Nonspecific complaints, 
pain in right hip 
from coxarthrosis, 
spontaneous 
recovery fro m  fever
8.5 7 Right hip N o  diagnosis S , C
12/25/F 75 Abdominal pain, 
extreme weight loss
3.9 4 N o s e , left axilla S ystem ic lupus erythematosus, 
nonspecific
lym phadenopathy of axilla
B, CT, blood
1 3/44/F 12 Dyspnea, heart 13.4 23 Ascending colon N o  diagnosis Blood, C
m urm ur, 
spontaneous 
recovery fro m  fever
ilH ■ * * M tn ■ M M M
(continued)
of 82%. The specificity was 69%. These results 
compare favorably with data in literature dealing with 
o radiopharmaceuticals (T able 2 ) .  Most scinti­
graphic studies in FUO have been performed with gal-
c it rale Ga 672"8,10,23 and 1 "In-WBCs.1 u! 1,24 For 
scintigraphic studies with Ga 67, sensitivity ranged 
from 75% to 100% and specificity varied widely, rang­
ing from 38% to 100%. In 111 In-WBC scintigraphy, 
sensitivity and specificity appeared to be much higher, 
ranging from 90% to 100% and 84% to 86%, respec­
tively. When these data are compared, "'In-WBC scin­
tigraphy seemed to perform somewhat better than 
Ga 67 scintigraphy and in In-IgG scintigraphy. How-
adhere to the criteria for FUO formu­
lated by Petersclorf and Beeson4*7,11,12; some even 
include postoperative patients with fever, who often 
have a localized abscess.4,5 Those results cannot be 
extrapolated to those patients with classic FUO, mak­
ing comparison of these data somewhat hazardous. 
Moreover, in most other studies, only a selection of
patients with FUO was included.3,3,8,10,11,13,22,23
Knockaert et alH found in patients with FUO that a 
positive Ga 67 scintigram increased the chances of reach­
ing a final diagnosis; 77% of patients with positive scans 
in contrast to .34% of those with negative scans were given
with the use of In-IgG: a tiro 
10 (77%) of 13 patients with a positive scan
of 11 patients with a negative scan. In
m
re patients ‘
te had afor a variety of indications,14,21 this tec
in comparison 
In-WBC scintigraphy, it has many advantages. First,
citrate Ga
I n - I g C tmethylpropyleneamine
is not secreted in the normal bowel, 
tection
dition, the radiation burden of gallium citrate Ga 67 is
r 111 ln-lgG, ie, 
lent of 27 and 15 mSv, respectively.21,25 In 
tion, sensitivity of labeled WBG seintigi 
limited by the absence of granulocyte influx in this
an that
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Table 1 .  Characteristics of Patients According to Results of Indium In 1 1 1  IgG S c a n s * (cont)
Patient/ 
Age, y/ 
Sex
ESR,
mm/h
14/25/F 89
1 5/77/M 1 1 2
1 6/62/M
1 7/52/M
«V* >*•** s* '  s'*. *•*' **•
Clinical D ata
Heart m u rm ur;
Indonesian travel 
C ou gh , diarrhea; 
artificial heart valves
96 Fatigue; spontaneous
recovery after 4 m o
40 Fatigue, slight weight
loss; pigeon fancier; 
spontaneous 
recovery after 10  mo
• . / i r
Leukocytes, 
X 1 0  VL
6,1
7 . 4
10.0
5.5
Fever
Duration,
wk
6
1 7
13
1 2
Localization of Uptake
True-Negative Scans
Equivocal (pelvis)
None
None
Equivocal (right lower 
abdom en)
Fin a l D ia g n o s is
Salmonella sepsis, prom pt 
response to antibiotics
H o d g k in ’s disease and lung 
cancer 
N o  diagnosis
N o  diagnosis
Additional
In ve s tig a tio n s t
X ,  blood, C
S, B, bronchoscopy
B M , C T , C, U S ,  
blood
X ,  B, C T , B, U S ,  C
18/46/M 14 0
1 9/63/F 1 1 2
20/53/F
2 1 /35/M
22/27/M
Myalgia of legs, 
fatigue, anorexia
Fatigue, lumbar pain, 
transient diarrhea; 
spontaneous 
recovery after 4  m o
1 4  Persistent recurrent
fever for > 4  y
5 Tick bite; recurrent
fever with headache; 
spontaneous 
recovery after 1 y
4 Fatigue; spontaneous
recover/ after 1 0  m o
5.5
11.1
4.6
4.4
7 .1
23/54/F
24/68/F
93 Heart m u rm u r, kidney
transplant, renal 
cysts
7 1  Scleroderma, heart
m urm ur, renal failure
1 1 . 7
1 4 .5
30
3
88
51
18
Equivocal (lungs) 
None
None
Equivocal (colon)
False-Negative Scans
5 None
5 None
Acute leukemia
N o  diagnosis
N o  diagnosis 
N o  diagnosis
N o  diagnosis
Infected renal cyst, culture 
negative after use of several 
antibiotics 
Infected central catheter with 
Staphylococcus epidermidis
C T , U S ,  B M ,
U S ,  C T , X ,  B,
blood, C
M R ,  C T , U S , 
blood, C
C T , X ,  B, C, 
U S
B, X
U S , colonoscopy, 
C, blood
S , C
C T , X ,  blood, U S ,  C
*US indicates ultrasound; CT, computed tomography; B, biopsy; C, culture; S, surgery; MR, magnetic resonance imaging; X, x-ray; BM, bone marrow 
aspiration; PE, pathologic examination; DSA, digital subtraction angiography; and Tc, technetium. 
t Investigations performed to verify the diagnosis are shown in boldface. For true-positive scans, all additional Investigations were performed for verification.
Figure 1 .  Patient 2. Abnormal uptake In the left hip and back (arrow) 
caused by spondylodiskitis.
Figure 2 .  Patient 3. Abnormal uptake in the right lower abdomen (arrow) 
caused by Crohn ’s disease.
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Table 2 .  Reports on Diagnostic Value of Scintigraphy in Patients With F U O *
Scan Result, No. (%)
Sensitivity, Specificity,
Source, y Scan N T P F P TN FN % % Remarks
et al,2 1990 G a  6 7 49 8 ( 1 6 ) 1 7  (35) ♦ « f ■ « t • « « t ■ * Abstract
Misaki et al,3 1990 Ga 6 7 56 23 (41 ) 1 0 ( 1 7 ) 1 9 ( 3 5 ) 4 ( 7 ) 85 65 Selected group, abstract
Hilson and Maisey/ 1 9 7 9 G a  6 7 61 4 7  ( 7 7 ) 3 ( 5 ) 11  (1 8 ) 0 ( 0 ) 1 0 0 7 9 No criteria for F U O ,  
also postoperative 
patients
Teates and Hunter,5 1 9 7 5 G a  6 7 4 2 9 ( 2 1 ) 5 ( 1 1 ) 25 (61 ) 3 ( 7 ) 7 5 83 Selected group, no criteria 
for F U O
Suga et al,6 1991 G a  6 7 36 1 7  ( 4 7 ) 0 ( 0 ) 1 5  (42) 4 ( 1 1 ) 80 10 0 Retrospective, selected, 
other criteria for F U O
Hablbian et ai,7 1 9 7 5
•
G a  6 7 22 1 2 ( 5 4 ) 5 (22) 3 ( 1 5 ) 2 ( 9 ) 86 38 Also postoperative 
patients, no definition 
of F U O
Knockaert et al,8 1989 G a  6 7 54 1 4  (26) 8 ( 1 5 ) 2 8 ( 5 1 ) 4 ( 7 ) 7 8 7 8 Criteria for F U O  of 
Petersdorf, selected
group
Larson et ai,23 1982 G a  6 7
\
40 1 0  (25) 9 .(2 3 ) 18  (45) 3 ( 7 ) 7 7 6 7 Criteria for F U O  of 
Petersdorf, selected 
group, other definition 
of true positive
Knockaert et al,® 1994 G a  6 7 1 4 5 42 (29) 40 (28) 54 (3 7 ) 9 ( 6 ) 82 5 7 Criteria for F U O  of 
Petersdorf, selected 
group, retrospective
Schm idt et al,1 0 1 9 8 7 In 1 1 1  W B C s 3 2 7 ( 2 1 ) 4 ( 1 3 ) 21 (66) 0 ( 0 ) 1 0 0 84 Criteria for FU O  of 
Petersdorf, selected 
group
Syrjälä et al,1 1 1 9 8 7 In 1 1 1  W B C s 68 1 9  (28) 7 ( 1 0 ) 40 (59) 2 ( 3 ) 90 85 Other criteria for F U O ,  
selected group
M cDougall et al,1 2 1 9 7 9 In 1 1 1  W B C s 1 3 3 (24) 1 ( 7 ) 9 ( 6 9 ) 0 ( 0 ) 1 0 0 90 N o  criteria for F U O  
mentioned, selected 
group
Davies and Garvie,24 1990 In 1 1 1  W B C s 28 3 ( 1 1 ) 5 ( 1 8 ) 18  (64) 2 ( 7 ) 7 1 86 Criteria for FU O  of 
Petersdorf, selected 
group, retrospective
Becker et al,1 3 1993 T c  a n ti-N C A 34 8 (24) 1 ( 3 ) 1 3  (38) 1 2 ( 3 5 ) 4 0 92 Criteria for F U O  of 
Petersdorf, selected 
group, retrospective
Present study In 1 1 1  Ig G 24 9 ( 3 8 ) 4 ( 1 7 ) 9 ( 3 8 ) 2 ( 8 ) 82 69 Criteria for F U O  of 
Petersdorf, selected 
group, retrospective
*#*»
* F U O  indicates fever of unknown origin; TP, true positive; F P , false positive; TN , true negative; F N , false negative; Ga 67, gallium citrate Ga 6 7; In 111,  
indium In 1 1 1 ;  Tc, technetium; W BCs, white blood cells; and N C A , nonspecific cross-reaching antigen.
of infection.“'1 In a prospective comparative study in sub­
acute infections, with the use of luIn-WBC and nlIn-
IgG scintigraphy, Oyen et al found a higher diagnostic 
accuracy of mln-IgG scintigraphy.
The need to draw blood and to isolate and label leu-
'S  m i m In-WBC and l,t)mTc-WBC scintigraphy 
more time consuming, complicated, and ,Un"  111
IgG scintigraphy. It takes 3 hours to prepare the radio­
pharmaceutical, and not every department of 
medicine has the facilities to label leukocytes. Of major
concern are the handling of blood and the possibility of
wrong patient.27 c is a
limitation to the use of all scintigraphic techniques, in­
cluding mln-IgG: lesions in organs with relatively high 
physiologic uptake, eg, liver, heart, spleen, and kid­
neys, can be missed. Because of these advantages and the 
high diagnostic yield, m In-IgG scintigraphy may be­
come the first choice in scintigraphic investigations in 
patients with FUO.
Since this study, like all studies on scintigraphic 
methods in FUO, is retrospective, the exact role of
1HIn-IgG scintigraphy in the diagnostic process of pa­
tients with FUO is unknown. Prospective studies are nec­
essary to
c
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